Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic determinants of thyroid function in children.
Mulder TA, Campbell PJ, Taylor PN, Peeters RP, Wilson SG, Medici M, Dayan C, Jaddoe VVW, Walsh JP, Martin NG, Tiemeier H, Korevaar TIM. Mulder TA, et al. Eur J Endocrinol. 2023 Aug 2;189(2):164-174. doi: 10.1093/ejendo/lvad086. Eur J Endocrinol. 2023. PMID: 37530217 Free PMC article.
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis.
Taylor PN, Collins KS, Lam A, Karpen SR, Greeno B, Walker F, Lozano A, Atabakhsh E, Ahmed ST, Marinac M, Latres E, Senior PA, Rigby M, Gottlieb PA, Dayan CM; Trial Outcome Markers Initiative collaboration. Taylor PN, et al. Among authors: dayan cm. Lancet Diabetes Endocrinol. 2023 Dec;11(12):915-925. doi: 10.1016/S2213-8587(23)00267-X. Epub 2023 Nov 3. Lancet Diabetes Endocrinol. 2023. PMID: 37931637 Free article.
Liothyronine prescribing in England: costs versus need.
Heald A, Stedman M, Okosieme B, Premawardhana L, Taylor P, Dayan C. Heald A, et al. Lancet. 2023 Dec 2;402(10417):2074-2075. doi: 10.1016/S0140-6736(23)01792-0. Epub 2023 Nov 15. Lancet. 2023. PMID: 37979592 No abstract available.
Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design.
Premawardhana LD, Taylor PN, Okosieme OE, Adlan MA, Obuobie EK, Dayan CM. Premawardhana LD, et al. Among authors: dayan cm. Front Endocrinol (Lausanne). 2023 Nov 16;14:1282608. doi: 10.3389/fendo.2023.1282608. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38034018 Free PMC article. Review.
186 results